Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 9, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • India
  • Page 5

Category: India

Weekly Biotech News of India

  • BiotechToday
  • India

Peeking into Portable Eye Examination Kit (PEEK).

bioxone October 21, 2020October 20, 2020 2

Husna, Amity University Kolkata Uncorrected refractive errors (URE) are a common cause of vision loss in children and affects almost 12.8 million children worldwide. Myopia (short-sightedness) is the most common eye-defect which can be severe if not corrected and 80-90% urban children suffer from myopic vision due to lack of time spent outdoors. Hypermetropia (long-sightedness) […]

Read More
  • BiotechToday
  • India
  • World

Covid Update: Moderna Vaccine on the Horizon!

bioxone October 20, 2020October 20, 2020

Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]

Read More
  • BiotechToday
  • India

The potentiality of Honey in The Treatment of Diabetes Mellitus?

bioxone October 15, 2020October 15, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA “Honey” is most commonly used in Supportive and Substitute Medicine mainly in the Indian Ayurvedic Medicine since ancient times, as an additive in the treatment of Diabetes Mellitus. But in recent times the use of honey gained effective potential for the treatment of diabetes because of the increase in the […]

Read More
  • BiotechToday
  • India
  • World

COVID 19-The Mask Paradox: Are you masking yourself from reality?

bioxone October 14, 2020October 14, 2020

Chitra Roy, University of Calcutta Recent research by the University of Georgia has provided solid support on the spread of COVID 19 through fine aerosols being circulated in enclosed space, thereby, persuading people to wear masks particularly indoors. Even though most of the documented COVID 19 transmissions are occurring at enclosed spaces with poor ventilation, […]

Read More
  • BiotechToday
  • India

COVID UPDATE: Decrease in daily active cases in India

bioxone October 13, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata The coronavirus, or the virus which has resulted in the whole world to shutdown, the ecosystem to change and us to depend completely on technology (to manage the economic conditions) and their immunity (since its more or less the survival of the fittest) first started its game in Wuhan, China. […]

Read More
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Read More
  • BiotechToday
  • India

Coronavirus | Government to map out cold storage facilities for COVID-19 vaccine delivery

bioxone October 11, 2020October 11, 2020 2

-Sagnik Nag, Amity University With the increasing cases of COVID fever, there’s still hope for upcoming vaccines within a few months. The hope came with a massive responsibility on the Government for mapping out its extensive cold storage to ensure the quick delivery of the vaccine across the country. A national expert group surveyed to […]

Read More
  • BiotechToday
  • India
  • World

Enhancement of antiviral effectiveness against viral respiratory pathogens by engineering Fc domain of antibodies

bioxone October 11, 2020October 10, 2020

-Richismita Hazra, Amity University Kolkata Antibodies serve as analytical barriers to viruses or viral infections. They play a dual role in communicating the existence of invading pathogens in infected cells, also, in interfering with the processes that are essential to the viral lifecycle. The antibodies activate phagocytes which is a potential mechanism of eradiating viruses. […]

Read More
  • BiotechToday
  • India
  • World

Can mutation make you lose your sense of smell?

bioxone October 10, 2020October 10, 2020 10

-Husna, Amity University Kolkata The loss in sense of smell and taste experienced most commonly due to viral fever is termed as Anosmia. Millions of olfactory receptor cells are present in our nasal cavity. These cells captures molecules with specific odour and activate a nerve response which then carries the signal to the brain where […]

Read More
  • BiotechToday
  • India

SKIN CANCER KILLING BANDAGE DEVELOPED BY IISc

bioxone October 9, 2020October 9, 2020 2

Rohit Bhattacharjee, Amity University Kolkata Skin cancer, the most common kind of cancer, is mainly caused due to excessive exposure to the UV rays from the sun. They are of two types:- melanoma ( develops from pigment-producing skin cells called melanocytes) and non-melanoma (developed from other skin cells). Though non-melanoma skin cancer is more widespread, […]

Read More

Posts navigation

1 2 3 4 5 6 7 8 9 10

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy